Get started
Sangamo Therapeutics, Inc.Sangamo Therapeutics, Inc.Sangamo Therapeutics, Inc.

Sangamo Therapeutics, Inc.

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals

SGMO trade ideas

SGMO: Caution AdvisedThe company we're looking at seems to be doing well, but let's not get too excited just yet. Here’s a simpler look at what’s happening: What the Charts Say : The RSI, which is a fancy way of saying how fast the stock price is moving, is at 83. This is usually a sign that the stock price might go down soon. In the past, when this number got really high, the stock price often fell by half or even more. So, even though the company looks good, it might be a good time to sell some shares and make a profit. What Might Happen Next : We're seeing some signs that tell us the stock price could drop a little, maybe to around $0.7, before it might go up again to somewhere between $2.5 and $3. But right now, the stock is very popular, maybe too popular, which can make it hard for its price to keep going up. Being Careful: The charts also show that people are getting very excited about this stock, maybe too excited. It's important not to get too greedy and think you can make a lot of money without any risk. If the price goes down, remember, you can always buy the stock again later. Patterns in the Price : The way the stock price has been moving looks like it might go down about 60% soon. But, there's also a pattern that suggests the price could go up to $3 by June if things in the economy get better. Thinking About the Big Picture: It’s not just about the charts. We should also think about how the company is doing, like if it’s making money and how it stands compared to other companies. This helps us decide if it’s a good idea to invest in the stock. What to Do: With all this information, it might be smart to sell some of your shares now to avoid losing money later. But keep an eye on things because there could be a good chance to buy more shares at a lower price. Remember, it's important to not put all your eggs in one basket, which means don’t invest all your money in just this stock. And, always have a plan in case things don’t go as expected. I'm not a financial advisor, so it's important to do your own research or consult a professional before making any investment decisions.
NASDAQ:SGMOShort
by MarketPax
4
SGMO - long -catalyst playSangamo Therapeutics Inc is a clinical-stage biotechnology company that translates ground-breaking science into genomic therapies transforming patients' lives using platform technologies in genome editing, gene therapy, gene regulation and cell therapy. The company's product pipeline includes Hemophilia, Central Nervous System, HIV, Lysosomal Storage Disorders, and Hemoglobinopathies. This is not a financial advice! Upcoming catalyst on 31st. of March Keep an eye on 0.65 , 1.10 and 1.70 levels- needs to get broken for a further upmove. SL under 0.3 TP approx. 2.8 Most info on the chart. Trade carefully!
NASDAQ:SGMOLong
by meitshels_smell_trades
1
$SGMO confluence of support (a lot going on)$SGMO has been correcting its 100% surge higher, I believe I have found enough evidence to suggest the $SGMO pullback has completed and represents a great buy opportunity: 1) +1 year long resistance is acting as support 2) reclaiming of the aVWAP from the bottom for the first time in 8 days 3) holding the 50 day EMA 4) consolidation occurring at the 50% retracement 5) price low of $13.48, AB = CD from peak terminates at $13.46 This idea reminds me of the technical situation of $OTRK (formerly known as $CATS) which I've linked below. The combination was a nearly straight line move higher off the bottom followed by a pullback into the long term resistance (now support), a key moving average (200 EMA) and a key fib retracement (61.8%)
NASDAQ:SGMOLong
by ETrades1
$SGMO Sangamo therapeutics clean setupsupport held past few weeks around $15.70. declining volume on sell-off. owns many patents and has deals to bring many CRISPR style medications through development testing and sales. strong revenue growth in a growing and increasingly accepted medical field. potential breakout target of $29. Biotech stocks are high risk as they depend on experiment success or failure (and success or failure of the competitors). failure means the sales expectations get wiped out instantly and so does the stock price. positive results boost sales and the value of the stock reflects this with rapid and dramatic price increase (magnified by the significance of the medications/treatments to investors perception).
NASDAQ:SGMOLong
by allthesmokeacquisitioncompany
$SGMOSangamo Therapeutics Inc (NASDAQ:SGMO) has been in a consolidation phase in the past two sessions and if the stock is able to move past the strong resistance of 18.64 with good volumes, then it will mean higher levels for the stock. The relative strength line is exhibiting a small negative divergence, which is usually a bearish sign, but in this particular case could be considered a typical move after a huge rally. The MACD indicator for the stock is still above its trigger line. A bullish breakout abv 18.64 would imply a continuation of the recent upbeat momentum, with $20 the pattern target on the buyers’ radar.
NASDAQ:SGMOLong
by SmoothJB